India to United Kingdom: Nivolumab Export Trade Route
India has recorded 4 verified shipments of Nivolumab exported to United Kingdom, representing a combined trade value of $20.9K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $5.2K USD. The leading Indian exporter is DR.REDDY'S LABORATORIES LTD, which accounts for 100% of total export value with 1 shipments worth $20.9K USD. On the buying side, LABCORP EARLY DEVELOPMENT is the largest importer in United Kingdom with $20.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Nivolumab corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $20.9K USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $5.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 27.4%, placing it at rank #11 among India's top nivolumab export destinations globally.
On the import side, key buyers of Indian nivolumab in United Kingdom include LABCORP EARLY DEVELOPMENT, ACCORD HEALTHCARE LTD, ACCORD HEALTHCARE LIMITED. LABCORP EARLY DEVELOPMENT is the single largest importer with 1 shipments valued at $20.9K USD.
Route Characteristics
- Average transit
